Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Sci Rep ; 11(1): 12514, 2021 06 15.
Artigo em Inglês | MEDLINE | ID: mdl-34131160

RESUMO

Multidrug resistance bacteria constitue an increasing global health problem and the development of novel therapeutic strategies to face this challenge is urgent. Antimicrobial peptides have been proven as potent agents against pathogenic bacteria shown by promising in vitro results. The aim of this study was to characterize the antimicrobial effects of PLNC8 αß on cell signaling pathways and inflammatory responses of human keratinocytes infected with S. aureus. PLNC8 αß did not affect the viability of human keratinocytes but upregulated several cytokines (IL-1ß, IL-6, CXCL8), MMPs (MMP1, MMP2, MMP9, MMP10) and growth factors (VEGF and PDGF-AA), which are essential in cell regeneration. S. aureus induced the expression of several inflammatory mediators at the gene and protein level and PLNC8 αß was able to significantly suppress these effects. Intracellular signaling events involved primarily c-Jun via JNK, c-Fos and NFκB, suggesting their essential role in the initiation of inflammatory responses in human keratinocytes. PLNC8 αß was shown to modulate early keratinocyte responses, without affecting their viability. The peptides have high selectivity towards S. aureus and were efficient at eliminating the bacteria and counteracting their inflammatory and cytotoxic effects, alone and in combination with low concentrations of gentamicin. We propose that PLNC8 αß may be developed to combat infections caused by Staphylococcus spp.


Assuntos
Antibacterianos/farmacologia , Queratinócitos/efeitos dos fármacos , Infecções Estafilocócicas/tratamento farmacológico , Staphylococcus aureus/efeitos dos fármacos , Linhagem Celular , Sobrevivência Celular/efeitos dos fármacos , Citocinas/genética , Regulação da Expressão Gênica/efeitos dos fármacos , Humanos , Peptídeos e Proteínas de Sinalização Intercelular/genética , Interleucina-1beta/genética , Infecções Estafilocócicas/microbiologia , Infecções Estafilocócicas/patologia , Staphylococcus aureus/patogenicidade , Ativação Transcricional/efeitos dos fármacos
3.
Sci Rep ; 10(1): 3580, 2020 02 27.
Artigo em Inglês | MEDLINE | ID: mdl-32107445

RESUMO

The use of conventional antibiotics has substantial clinical efficacy, however these vital antimicrobial agents are becoming less effective due to the dramatic increase in antibiotic-resistant bacteria. Novel approaches to combat bacterial infections are urgently needed and bacteriocins represent a promising alternative. In this study, the activities of the two-peptide bacteriocin PLNC8 αß were investigated against different Staphylococcus spp. The peptide sequences of PLNC8 α and ß were modified, either through truncation or replacement of all L-amino acids with D-amino acids. Both L- and D-PLNC8 αß caused rapid disruption of lipid membrane integrity and were effective against both susceptible and antibiotic resistant strains. The D-enantiomer was stable against proteolytic degradation by trypsin compared to the L-enantiomer. Of the truncated peptides, ß1-22, ß7-34 and ß1-20 retained an inhibitory activity. The peptides diffused rapidly (2 min) through the bacterial cell wall and permeabilized the cell membrane, causing swelling with a disorganized peptidoglycan layer. Interestingly, sub-MIC concentrations of PLNC8 αß substantially enhanced the effects of different antibiotics in an additive or synergistic manner. This study shows that PLNC8 αß is active against Staphylococcus spp. and may be developed as adjuvant in combination therapy to potentiate the effects of antibiotics and reduce their overall use.


Assuntos
Antibacterianos/farmacologia , Bacteriocinas/farmacologia , Staphylococcus/efeitos dos fármacos , Antibacterianos/química , Bacteriocinas/química , Bacteriocinas/genética , Farmacorresistência Bacteriana , Testes de Sensibilidade Microbiana , Staphylococcus/crescimento & desenvolvimento
4.
Future Microbiol ; 14: 195-205, 2019 02.
Artigo em Inglês | MEDLINE | ID: mdl-30648887

RESUMO

AIM: Bacteriocins are considered as promising alternatives to antibiotics against infections. In this study, the plantaricins (Pln) A, E, F, J and K were investigated for their antimicrobial activity against Staphylococcus epidermidis. MATERIALS & METHODS: The effects on membrane integrity were studied using liposomes and viable bacteria, respectively. RESULTS: We show that PlnEF and PlnJK caused rapid and significant lysis of S. epidermidis, and induced lysis of liposomes. The PlnEF and PlnJK displayed similar mechanisms by targeting and disrupting the bacterial cell membrane. Interestingly, Pln enhanced the effects of different antibiotics by 30- to 500-fold. CONCLUSION: This study shows that Pln in combination with low concentrations of antibiotics is efficient against S. epidermidis and may be developed as potential treatment of infections.


Assuntos
Antibacterianos/farmacologia , Bacteriocinas/farmacologia , Staphylococcus epidermidis/efeitos dos fármacos , Sequência de Aminoácidos , Bacteriocinas/química , Membrana Celular/efeitos dos fármacos , Contagem de Colônia Microbiana , Combinação de Medicamentos , Sinergismo Farmacológico , Lipossomos , Testes de Sensibilidade Microbiana , Viabilidade Microbiana/efeitos dos fármacos , Precursores de Proteínas/farmacologia , Infecções Estafilocócicas/tratamento farmacológico , Infecções Estafilocócicas/microbiologia , Staphylococcus epidermidis/citologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...